Daron Evans, President and CEO at NEPHROS INC (NEPH), bought 30,000 shares at $0.26 ($8K) on 2017-05-19, disclosed to the SEC on 2017-05-19.
Open-market purchase of $8k NEPH by President and CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.26 | 22,500 | $6K | 75.0% |
| 2 | $0.26 | 7,500 | $2K | 25.0% |
| Total | $0.26 avg | 30,000 | $8K | 100% |
| Filing → |
| RZLT | BUY | 2025-06-24 | $20K | — | Filing → |
| RZLT | BUY | 2025-03-28 | $58K | — | Filing → |
| RZLT | BUY | 2024-12-18 | $43K | — | Filing → |